Hexarelin
This profile covers Hexarelin. Start with the peptide's intended use, human evidence and product-quality limitations before the mechanism details.
Technical catalog description
Hexarelin is the most potent of the synthetic GHRPs. It produces larger GH pulses than GHRP-2, GHRP-6, or Ipamorelin, but this comes with meaningful cortisol and prolactin elevation that limits cycle length and dose flexibility.
Hexarelin has attracted attention beyond pure GH secretagogue use because of preclinical data suggesting cardioprotective properties through a GH-independent pathway acting on cardiac muscle and potentially the CD36 receptor. Some users include it specifically for these potential cardiovascular benefits.
Read next
Hexarelin is the GHRP for users who have already used the cleaner options and specifically want the strongest secretagogue pulse available. That is a narrow use case, and the compound earns it because it is meaningfully more potent than the rest of the family.
Prolactin, cortisol, and desensitization are concerns discussed in this profile. No amount or cycle length is established here as reliably tolerable.
Cortisol and prolactin elevation, more significant than with other GHRPs
Appetite increase, water retention, and faster receptor tachyphylaxis
prolactin if symptomatic
cortisol if mood or sleep changes
bodyweight and edema
Users prone to prolactin issues or already stacking other prolactin-elevating compounds
Anyone running it continuously without cycling off to allow receptor recovery
Hexarelin is chosen for two overlapping reasons. Some users want the strongest GH secretagogue available and are willing to cycle it shorter and monitor more carefully to get there. Others have read the preclinical cardiac data and include it specifically for potential cardioprotective benefits during otherwise demanding compound use. The cardiac story is interesting, but it is not established in humans.
GH-related feedback (recovery, sleep, body composition over time) follows the same slow story as other secretagogues. The potency does not compress the timeline. It just means the peak signal is higher when everything is working. Prolactin and cortisol effects, if they emerge, show up earlier than the benefits.
Running it too long without cycling off. Assuming the strongest option produces the best long-term result rather than the highest peak signal in the short window before tachyphylaxis sets in. Stacking it with other prolactin-raising compounds without monitoring.
Compared with GHRP-2, hexarelin is more potent but less sustainable and harder on prolactin. Compared with Ipamorelin, it is dramatically louder in both benefits and side effects. For most intermediate users, GHRP-2 or Ipamorelin is the better starting point.